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Edited by Felix WielandAbstract Recent studies have shown a dampened amplitude of
clock gene rhythm in the heart and liver of streptozotocin (STZ)-
treated rats and mice, however it is unknown whether impairment
is due to dysfunction of the suprachiasmatic nucleus (SCN) or
not. Rhythmic expression of mPER2 was dampened in the STZ-
treated mouse liver but not SCN and cerebral cortex. Injection of
insulin could normalize an impairment of mPer2 and mPER2
expression rhythm in the liver, when it was injected at nighttime,
but not at daytime. In the present study, we demonstrated that
insulin-dependent diabetes impaired oscillation of the peripheral
clock gene and its product. Insulin injection can recover
dampened oscillation of the peripheral clock depending on its
injection time.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Streptozotocin1. Introduction
Diabetes mellitus is a syndrome characterized by hypergly-
cemia resulting from the absolute or relative impairment of
insulin secretion and/or insulin action. There are two main
types of diabetes mellitus known as type I (insulin-dependent)
and type II (insulin-independent) [1]. Recent evidence suggests
that the binding of NPAS2 and CLOCK to the E-box depends
on the ratio of NAD to NADH [2]. These molecules are es-
sential components of the respiratory enzyme chain and the
ratio between them ﬂuctuates according to changes in cellular
metabolism. Thus, diabetes may aﬀect molecular mechanism
of circadian clock in the liver through impairment of energy
metabolism. Interestingly, recent study showed that all clock
and clock-controlled genes examined possess circadian ad-
vanced and dampened rhythms of gene expression in the
streptozotocin (STZ)-induced type I diabetic rat heart [3] and
mouse liver [4]. However, these experiments still possess a
question whether impairment of clock gene expression refers to
impairment of suprachiasmatic nucleus (SCN) clock function
or that of peripheral clock function. In this experiment, we* Corresponding author. Fax: +81-424-50-2271.
E-mail address: shibatas@waseda.jp (S. Shibata).
Abbreviations: LD, light–dark; SCN, suprachiasmatic nucleus; STZ,
streptozotocin; ZT, Zeitgeber time
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doi:10.1016/j.febslet.2004.07.036examined mPER2 expression in the SCN and mPer2 and
mPER2 in the liver in STZ-treated diabetic mice.
Diabetes mellitus induced by STZ treatment is a syndrome
characterized by hyperglycemia resulting from the absolute
impairment of insulin secretion, therefore insulin treatment is
necessary to attenuate the diabetic syndrome. Therefore, we
examined whether daily insulin injection can recover the im-
pairment of circadian expression of mPer2 and mPER2 in the
STZ-treated mouse liver. We injected insulin at nighttime or
daytime onset in the light–dark (LD) housing condition, be-
cause daily injection of insulin may facilitate the recovery of
circadian oscillation, when it was injected during eating time
but not during resting time.2. Materials and methods
2.1. Animals and induction of diabetes
Male ddY mice (6 weeks old) were obtained from Takasugi Exper-
imental Animals (Saitama, Japan). Animals were maintained on a LD
cycle (LD 12 h light: 12 h dark, with lights on at 8:30 a.m.) at a room
temperature of 23 C and allowed free access to food and water. All
animals were treated in accordance with the Law (No. 105) and No-
tiﬁcation (No. 6) of the Japanese Government.
2.2. Experimental design
Diabetes was induced by a single intraperitoneally injection of STZ
(200 mg/kg; Wako Chemical Osaka, Japan) at Zeitgeber time (ZT) 11
(day 0) into 15-week-old mice and blood glucose level was checked 5
days after STZ injection. Five days after STZ, animals were sacriﬁced
every 6 h from ZT 0 to 18 on day 5 (n ¼ 3–4 for each time point) for
measurement of mPer2 and mPER2 expression.
In order to elucidate the eﬀect of insulin on impairment of mPer2
and PER2 expression, mice were divided into three groups. The ﬁrst
group animals were injected with vehicle (0.1 M citrate sodium buﬀer)
at ZT 11 (day 0), and 5 days after vehicle injection, animals received a
subcutaneous injection of saline at ZT 11.5 or ZT 23.5 for further 6
consecutive days. On the next day of ﬁnal injection (day 10), mice were
sacriﬁced at ZT 0, 6, 12, and 18 (n ¼ 3 for each time point). The second
and third group animals were injected with STZ (200 mg/kg) at ZT 11
(day 0), and 5 days after STZ injection, animals received a subcuta-
neous injection of saline for second group or insulin (5 IU/kg, Sigma)
for third group at ZT 11.5 or ZT 23.5 for further 6 consecutive days.
On the next day of ﬁnal injection (day 10), mice were sacriﬁced at ZT 0,
6, 12, and 18 (n ¼ 3–5 for each time point). Next, we examined the
acute eﬀect of insulin on the impairment. Five days after STZ injection
mice were received saline or insulin (5 IU/kg) at ZT 11.5, and then
sacriﬁced 2 or 4 h after insulin injection.
2.3. RT-PCR
Mice were deeply anesthetized with ether and intracardially perfused
with ice-cold saline to remove excess blood. A block-shaped sample of
liver (approximately 100 mg wet weight) was taken for measurement of
liver clock gene expression by RT-PCR. Total RNA from each sampleation of European Biochemical Societies.
Fig. 1. Eﬀect of STZ on mPer2 and mPER2-ir cells expression in the
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GA). A One-Step RT-PCR System Platinum Version (Invitrogen, CA)
was used for a RT-PCR containing 100 ng of RNA. mPer2 and b-actin
cDNA was ampliﬁed using GeneAmp9900 (Applied Biosystems, CA).
Procedure of RT-PCR was the same as that reported in our previous
paper [5,6].
2.4. mPER2 immunohistochemistry
Mice (n ¼ 3 mice for each time point) were deeply anesthetized with
ether and intracardially perfused with 0.1 M phosphate buﬀer (PB)
(pH 7.4) containing 4% paraformaldehyde (PFA). Brains and livers
were removed, post-ﬁxed in 0.1 M PB containing 4% PFA for 24 h at 4
C, and transferred into 20% sucrose in 0.1 M PB for 72 h at 4 C.
Immunoreactivity process was exactly the same as that reported in our
previous paper [7].
2.5. Measurement of the number of mPER2 immunoreactive cells in the
SCN and liver
The number of mPER2 immunoreactive (mPER2-ir) cells of SCN
was counted by Scion Image Beta 4.02. The threshold value was set
to 120, and the nuclear size was set as a minimum of 10 and a
maximum of 40 pixels. mPER2-ir cell numbers from ﬁve slices, that
contain mPER2-ir cells from rostral to caudal SCN, were averaged
and used for cell number of each mouse. In the liver, three photo-
graphs around central vein of hepatic lobe were taken per individual
mouse. These photographs were printed (65 85 mm) and the
number of mPER2-ir cells of liver contained in the division deﬁned
arbitrarily (40 50 mm) was counted by un-notiﬁed person. Then,
averaged cell number was calculated from each animal, and averaged
cell number and standard error was obtained from three animals for
each time point.
2.6. Measurement of blood glucose concentration
Just prior to liver isolation, 0.5 ml of blood was withdrawn from the
mouse heart and serum glucose level was measured by Novo Assist
Plus (Novo Nordic Pharma, Tokyo, Japan) in the manner recom-
mended by The manufacturer.
2.7. Statistical analysis
The values were expressed as meansS.E.M. The signiﬁcance of
diﬀerences between groups at each time point was determined by the
Student’s t test. Rhythmicity of each group was tested by one-way
ANOVA. Two-way ANOVA was used for comparing the daily ex-
pression rhythm of the two groups.liver on day 5. Mice were injected with STZ (200 mg/kg) or vehicle and
housed for next 5 days (day 0–5). (A) The mPer2 mRNA expression
demonstrated by RT-PCR for analysis. (B) Time course of mPer2
mRNA expression in the vehicle- (closed circle) (n ¼ 3 for each time
point) and STZ-treated (open circle) (n ¼ 4 for each time point) group
mice liver. Relative mRNA levels of mPer2 are shown as ratios to b-
actin. , P < 0:05 vs. vehicle (Student’s t test). (C) Representative sec-
tions of hepatic slice. Square area (40 50 mm) along with central vein
shows the tissue area in which the number of mPER2-ir cells (upper
panel) was counted, and the enlargement was shown in the lower pa-
nel. (D) Representative sections containing mPER2-ir cells in the liver
of vehicle- or STZ-treated mice. Daily ﬂuctuation of mPER2-ir cell
numbers in the liver of vehicle- (n ¼ 3 for each time point) or STZ-
treated mice (n ¼ 3 for each time point). , P < 0:05; , P < 0:01 vs.
vehicle (Student’s t test).3. Results
3.1. Eﬀect of STZ on mPer2 gene expression and mPER2-ir
cells in the SCN and liver
The success of diabetes induction was assessed by measuring
both body weight and serum glucose level 5 days after STZ
injection. Body weight was signiﬁcantly decreased in STZ-
treated mice (28 0.10, n ¼ 12) compared to vehicle mice
(34 0.69, n ¼ 12) 5 days after the treatment. Serum glucose
level was 3.8-fold higher in STZ-treated mice (570 13 mg/100
ml P < 0:01, Student’s t test) compared with vehicle mice
(151 5 mg/100 ml). Fig. 1A and B shows daily mPer2 gene
expression of vehicle- or STZ-treated group in the liver. In
STZ group, mPer2 gene expression was dampened at ZT 18.
Two-way ANOVA analysis (treatment time course) demon-
strated a signiﬁcantly diﬀerent expression in mPer2
(F ð3; 20Þ ¼ 17:4; P < 0:01) between vehicle- and STZ-treated
group.
Next, we observed daily change of cells expressing mPER2
immunoreactivity at four time points in the liver of vehicle- or
STZ-treated mice. mPER2-ir cells in the liver were located
across almost entire hepatic tissue at ZT 18. Along with central
vein, mPER2-ir positive nuclei were well observed as the dark
spots (Fig 1C). Although vehicle-treated animal showed a cleardaily rhythm of mPER2-ir cell numbers, at ZT 6 there were
relatively few mPER2-ir cells (Fig. 1C). The positive cell
numbers were dramatically reduced at ZT 0 and 18 in the STZ-
treated mice (Fig. 1D).
Although mPER2-ir SCN cells were located across almost
entire SCN at ZT 12 and 18 (Fig. 2), mPER2 immunoreactivity
was preferentially observed in the nucleus of SCN cells. In
both vehicle- or STZ-treated mice, a clear daily rhythm of
mPER2-ir cell was observed in the SCN with a peak at ZT 12.
Thus, daily rhythm of mPER2-ir cells in the SCN did not diﬀer
between both groups (Fig. 2), Similar to the SCN, daily
Fig. 3. Eﬀect of insulin on the expression of mPer2 and mPER2-ir cells
in the liver of STZ-treated mice. Mice were injected with STZ (200 mg/
kg) or vehicle, and housed for next 5 days (day 0–5). Then, STZ-
treated mice were injected with insulin (closed circle) (5 IU/kg) or sa-
line (open circle). Vehicle-treated mice were injected with saline (open
triangle) at ZT 11.5 (A) and (B) or 23.5 (C) and (D), respectively, for 6
consecutive days (day 5–10). (A) and (C) The mPer2 mRNA expres-
sion demonstration by RT-PCR. (B) and (D) Expression of mPer2
mRNA in the vehicle-saline (n ¼ 3), STZ-saline (n ¼ 3) or STZ-insulin
injected groups at ZT 11.5 or ZT 23.5 (n ¼ 4–5 for each time point).
Relative mRNA levels of mPer2 are shown as ratios to b-actin.
, P < 0:05; , P < 0:01 STZ-insulin vs. STZ-saline; #, P < 0:05;
##, P < 0:01 vehicle-saline vs. STZ-saline (Student’s t test). (E) Rep-
resentative sections containing mPER2-ir cells in the liver of each
group (vehicle-saline, STZ-saline, or STZ-insulin at ZT l 1.5). Lower
panel shows daily ﬂuctuation of mPER2-ir cell numbers in the liver of
vehicle-saline (n ¼ 3 for each time point) or STZ-saline or STZ-insulin-
treated mice (n ¼ 3 for each time point). , P < 0:05; , P < 0:01 STZ-
insulin vs. STZ-saline; #, P < 0:01; ##, P < 0:05; vehicle-saline vs.
STZ-saline (Student’s t test).
Fig. 2. Eﬀect of STZ on the number of mPER2-ir cells in the SCN.
Upper panel shows representative sections containing mPER2-ir cells
in the SCN of mice. Lower panel shows a daily ﬂuctuation of mPER2-
ir cell numbers in the SCN of vehicle- (n ¼ 3 for each time point) or
STZ-treated mice (n ¼ 3 for each time point).
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is same between both groups (data not shown).
3.2. Eﬀect of daily insulin injection on the expression of mPer2
gene and mPER2-ir cells in the SCN and liver of
STZ-treated mice
We examined the eﬀect of insulin injection for 6 consecutive
days on mPer2 gene expression and mPER2-ir cells in the SCN
and liver of STZ-treated mice. Serum glucose level was de-
creased 30 min after insulin injection at both injection times
(225 61 mg/100 ml for ZT 11.5 injection; 253 10 mg/100 ml
for ZT 23.5 injection), but it returned to high level 6.5 h after
insulin injection (464 17 mg/100 ml for ZT 11.5 injection;
484 42 mg/100 ml for ZT 23.5 injection). In the liver, STZ-
saline group again showed a dampened mPer2 gene expression
(Fig. 3A–D) and weak expression rhythm of mPER2-ir cell
number (Fig. 3E). Two-way ANOVA analysis (treat-
ment time course) demonstrated a signiﬁcant diﬀerence of
mPer2 expression between STZ-saline and STZ-insulin groups
(F ð3; 23Þ ¼ 34:0, P < 0:01), when insulin was administrated at
ZT 11.5 (Fig. 3A and B).
Two-way ANOVA analysis (treatment time course) dem-
onstrated no signiﬁcant diﬀerence ofmPer2 expression between
STZ-saline and STZ-insulin groups (F ð3; 23Þ ¼ 1:5; P > 0:05),
when insulin was injected at ZT 23.5 (Fig. 3C and D). mPER2-
ir positive cells were clearly increased at ZT 18 in comparison
with the saline injection in STZ-treated mice (Fig. 3E), when
insulin was injected at ZT 11.5.
In the SCN, a signiﬁcant daily rhythm in the number of
mPER2-ir positive cells was found with peak at ZT 12 in either
saline or insulin injection group. Thus, insulin injection at ZT
11.5 or 23.5 did not aﬀect mPER2-ir expression in the SCN
(Fig. 4).
3.3. Acute eﬀect of insulin on the expression of mPer2 and
mPER2-ir cells in the liver of STZ-treated mice
In order to reveal that acute injection of insulin is suﬃcient
for the recovery of the impairment, we examined the acute
eﬀect of insulin injection on mPer2 expression and number ofmPER2-ir cells in the STZ-treated mouse liver. Serum glucose
level was decreased 2 h (258 74 mg/100 ml for insulin injec-
tion; 604 29 mg/100 ml for saline injection, P < 0:01, Stu-
dent’s t test) and 4 h (417 28 mg/100 ml for insulin injection;
559 7 mg/100 ml for saline injection, P < 0:01, Student’s t
test) after insulin injection, but it returned to high level 6 h
Fig. 4. Eﬀect of insulin on number of mPER2-ir cells in the SCN of
STZ-treated mice. STZ-treated mice were injected with insulin (5 IU/
kg) at ZT 11.5 (closed circle) or 23.5 (open circle), or injected with
saline at ZT 11.5 (open triangle) for 6 consecutive days (day 5–10).
Upper panel shows representative mPER2 immunostained sections
containing the SCN of each group. Lower panel shows daily ﬂuctua-
tion of mPER2-ir cell numbers in the SCN of each group (n ¼ 3).
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ml for saline injection). Insulin injection increased mPER2-ir
liver cell in STZ-treated mouse 2 and 4 h after injection
(Fig. 5B). Similar to the data of mPER2-ir expression, acute
injection of insulin elevated mPer2 gene expression in STZ-
treated mouse liver 2 h after injection (Fig. 5A).Fig. 5. Acute eﬀect of insulin injection on expression of mPer2 and
mPER2-ir cells in the liver of STZ-treated mice. Mice were injected
with STZ (200 mg/kg) and housed for next 5 days (day 1–5). Insulin (5
IU/kg) or saline were injected into mice at ZT 11.5 on day 5. Then mice
were sacriﬁced 2 or 4 h after injection. (A) The mPer2 mRNA ex-
pression demonstration by RT-PCR. Time course of mPer2 mRNA
expression in the mice liver after saline (control group; white box) or
insulin (insulin group; black box) injected at ZT 11.5 (n ¼ 3–4). Rel-
ative mRNA levels of mPer2 are shown as ratios to b-actin. , P < 0:05
STZ-saline vs, STZ-insulin (Student’s t test). (B) Representative PER2
immunostained sections containing the liver of each group. Time
course of mPER2-ir cells after saline (control group; white box) or
insulin (insulin group, black box) injected at ZT 11.5 mice liver
(n ¼ 3–4). , P < 0:01 STZ-saline vs. STZ-insulin (Student’s t test).4. Discussion
In the present experiment, we found that the daily oscillation
of mPer2 and mPER2-ir cell was severely attenuated and the
peak time was advanced from ZT 18 to 12 in the liver of STZ-
treated mice. Whereas,amplitude mPER2 expression in the
SCN was unaﬀected by STZ injection. These results suggest
that oscillation of the peripheral oscillator but not central SCN
oscillator is impaired in STZ-treated diabetic mouse.
Similar results were obtained from study of the STZ-treated
rat heart [3] and mouse liver [4]. Our present ﬁnding supports
the fact that a dampened oscillation in the STZ-injected mouse
liver was observed in not only mPer2 but also mPER2 ex-
pression. Daily oscillation of mPER2, not only in the SCN but
also in the cerebral cortex, did not diﬀer between vehicle- and
STZ-injected mice. In the constant darkness condition, STZ-
injection mice showed an almost similar free-running period as
control mice (data not shown). These results lead us to believe
that the central oscillator in the SCN and cerebral cortex is not
altered in STZ-treated diabetic mice and that the diabetes-in-
duced dampened oscillation of the peripheral clock does not
result from change in the central clock oscillation. The mech-
anism of damping oscillation in the liver of STZ-treated mouse
is still unknown. Recent evidence suggests that the binding of
NPAS2 and CLOCK to the E-box gene depends on the ratio
of NAD to NADH [2]. These molecules are essential compo-
nents of the respiratory enzyme chain and the ratio between
them ﬂuctuates according to changes in cellular metabolism.Diaz-Munoz et al. [8] reported that the NAD:NADH ratio was
aﬀected by restricted feeding condition. Such a ratio change in
STZ-treated mouse may contribute to impairment of mPer2
and mPER2 expression in the liver. Further studies are needed
to examine whether the change in the ratio of NAD:NADH
can rescue abnormality of peripheral clock gene expression in
STZ-treated mice.
The change of mPer2 and mPER2 in the STZ-treated mouse
liver suggests that insulin, leptin [9] or other factors known to
be altered by both types of diabetes such as corticosterone
[10,11] or growth hormone [12] may modulate synchronization
210 K. Kuriyama et al. / FEBS Letters 572 (2004) 206–210of the peripheral oscillator. Actually, corticosterone is reported
to be a possible factor for entrainment of peripheral clock [13].
Further studies are needed to elucidate the interactions be-
tween peripheral clock gene function and diabetic functional
deﬁcits.
Daily injection of insulin may recover the impairment of
mPer2 and mPER2 expression rhythm in the STZ-treated
mouse liver. In the SCN, however insulin injection at activity
onset or oﬀset did not aﬀect mPER2 expression. The present
result demonstrated an importance of injection-time diﬀerence
in recovery eﬀect on impaired clock of the liver. Daily injection
at activity onset time, in which feeding behavior usually initi-
ates, normalized the impairment of mPer2 and mPER2 ex-
pression rhythm in the liver. This result strongly suggests that
daily insulin injection not only attenuated the diabetic syn-
drome but also recovered the peripheral circadian clock
function. It was reported that insulin acutely increased Per1
and Per2 gene expression in the Rat-1 ﬁbroblast [14]. There-
fore, injection of insulin may directly increase mPer2 gene
expression and mPER2 expression to the normal level.
Alternately, food intake after insulin injection may increase
mPer2 gene and mPER2 expression in STZ-treated mouse. In
the present experiment, we actually observed that both mPer2
expression and mPER2-ir cell increase 2 and 4 h after insulin
injection, along with increase of food intake (data not shown).
In order to decide whether the eﬀect of insulin on the clock
gene expression is speciﬁc eﬀect or just a consequence of the
altered glucose concentration, mPer2 expression was examined
after insulin and insulin+ glucose (5 g/kg) injection. As there
are similar increases of mPer2 gene expression in both groups
(data not shown), insulin-induced mPer2 gene expression
prefers a speciﬁc eﬀect. Recent in vitro experiment suggests the
above possibility, because glucose administration decreased
Per1 and Per2 gene expression in Rat-1 ﬁbroblast [15]. Al-
though locomotor activity level was slightly decreased by STZ
injection, insulin injection unaﬀected activity level (data not
shown). Thus, the insulin recovered the impairment of mPer2
and mPER2 expression without aﬀecting activity.As single injection of insulin is enough to recover the deﬁcit
of mPER2 and mPer2 gene expression,daily injection of insulin
facilitated the recovery of this deﬁcit. Thus, present result
shows the impact of insulin treatment on clock gene expression
in the liver of diabetic mice.
In summary, we demonstrated that mPer2 as well as mPER2
expression rhythm was impaired in STZ-treated mouse liver
without aﬀecting SCN mPER2 expression rhythm, and that
insulin injection at appropriate clock time could recover the
impaired peripheral clock function in diabetic mice.References
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